SPRED1 disorder and predisposition to leukemia in children.
Pasmant
Eric
E
Ballerini
Paola
P
Lapillonne
Helene
H
Perot
Christine
C
Vidaud
Dominique
D
Leverger
Guy
G
Landman-Parker
Judith
J
D048868:Adaptor Proteins, Signal Transducing; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D001064:Appendicitis / Q000150:complications; D002471:Cell Transformation, Neoplastic / Q000235:genetics; D011905:Genes, ras; D020022:Genetic Predisposition to Disease; D006330:Heart Defects, Congenital / Q000235:genetics*; D006801:Humans; D007223:Infant; D047908:Intracellular Signaling Peptides and Proteins / Q000172:deficiency* / Q000235:genetics / Q000502:physiology; D007948:Leukemia, Monocytic, Acute / Q000188:drug therapy / Q000235:genetics*; D020935:MAP Kinase Signaling System; D008297:Male; D008565:Membrane Proteins / Q000172:deficiency* / Q000235:genetics / Q000502:physiology; D020752:Neurocutaneous Syndromes / Q000235:genetics*; D011552:Pseudomonas Infections / Q000150:complications; D012074:Remission Induction; D018805:Sepsis / Q000150:complications
D048868:Adaptor Proteins, Signal Transducing; D047908:Intracellular Signaling Peptides and Proteins; D008565:Membrane Proteins; C504812:SPRED1 protein, human